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There are problems with using autogenous grafts despite 
their superior osteogenic capacity and biocompatibility. 
Graft harvesting increases pain, lengthens operative time, 
increases blood loss and adds another site for possible 
infection. All of these add to perioperative miorbidity. 
• i ‘ 
The ceramics available today for orthopaedic research 
are biocompatible mixture of" calcium phosphates. Each has a 
distinct chemical composition and crystalline structure. 
Some are almost entirely hydroxyapatite (HA), 
Caio(PO4)6(OH)2, and others predominantly Tricalcium 
phosphate (TCP), Ca3(P04)2. Other products have various 
proportions of the two. No one has yet found the optimum 
’丨 
ratio of hydroxyapatite to tricalcium phosphate or the 
minimum acceptable ratio of cancellous bone with either 
hydroxyapatite or tricalcium phosphate. Hydroxyapatite is 
more slowly resorbed than tricalcium phosphate, and 
frequently large residuals are still present years after the 
fracture is healed. So in this research, I try to use the 
granulated suspension form of hydroxyapatite to see weather 
this form will be absorbed or not. One thing I forgot is, 
this bone substitute should fill in press fit manner, so 
this time we could not see the osteoconductive effect of 
hydroxyapatite. 
This study was performed to quantitate the bone 





Powder form of tricalcium phosphate and granulated 
suspension of hydroxyapatite were evaluated. 
These bone substitute were implanted into the diaphyses 
' I . , 
(cortical bone) and metaphysis (cancellous bone) of rabbits 
tibiae for 3, 6, 12, and 24 weeks. Size of the window we 
created was 1 0 x 5 mm ( ) in shape. This is the biggest 
hole, we are able to created. 
Antibiotics prophylaxis consisting of cephalexin 2 0 
mg/kg BW was given as a single dose before surgery. 
X ray were taken after surgery and sacrificegp 
Immediate weight bearing was allowed. 
Tetracyclin staining were injected intravenously, 2 0 
mg/kg BW. Groups I and V, tetracyclin injection was given 4 
day before sacrificed. Groups II, III, VI, and VII, 
tetracyclin injection were given twice, 12, and 4 days .pa 
before sacrificed. Groups IV, and VIII, tetracyclin 
injection were given thrice, 21, 12, and 4 days before 
sacrificed. 
The specimen were then dehydrated and embedded in 
methyl methacrylate in standard manner. 
Superficial staining of toluidine blue to a thick 




The quantity of regenerated bone, and the whole window 
of cortical area was measured for cortical bone 
histomorphometry, and an area of 4 x 4 cm^ was measured for 
cancellous bone histomorphometry. 
Cortical group: 
At 3 weeks after implantation, no regenerated bone 
see at the edge of the window. 
At 6 and 12 weeks, new bone growth were there, but 
majority at periosteum site. 
At 24 weeks, TCP is work as an osteoconductive, 
because it was rounding by new bone formation. HA has 
1 
disappeared, and because HA (granulated suspension form) can 
not be applied in press fit manner so its osteoconductive 
：! • ： 
effect can not work, new bone growth mainly depend on how 
much periosteum protruding from the edge of the window. 
Cancellous group: 
We can not find the different between using bone 
substitute TCP and HA to the control.(table 4) These maybe 
affected by the small amount of cancellous bone in tibia 
plateau of rabbit. 
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THE BIOLOGICAL BEHAVIOR OF TRICALCIUM PHOSPHATE AS A BONE 
SUBSTITUTE IN ANIMAL MODEL ； 
« 
CHAPTER ONE - INTRODUCTION 
Bone grafting is an essential operative procedure in 
Orthopaedic Surgery. The application is so wide that all 
orthopaedic surgeons should not only be familiar with the 
common ways of practice, but should be keeping up with the 
current, up-to-date knowledge. Bone grafting is required 
I , 
wherever a bone defect is encountered unless the defect is 
small, viz., less than 0.5 cm in width and does not cover 
the whole surface area of the bone. Bone grafting therefore 
is widely demanded in the treatment of (1) fractures, where 
injury produces directly or indirectly large bone losses, 
(2) bone tumors, resection of which leaves large bone gaps, 
(3) bone infections where bone defects result from necrosis, 
！ 
(4) limb lengthening osteotomy, (5) arthrodesis and (6) 
special reconstructive requirements- wh^re bone deficiency 
hinders proper implant fixation, e.g. artificial hip joint 
cup in a deficient acetabular roof. Henceforth, it is 
obvious that not only the orthopaedic surgeon with 
specialized skill will need the concept and technique of 
bone grafting, but the average ones would be equally 
required to do so. 
The simplest and most commonly used bone graft has been 
cancellous chip graft. This graft is popular because it is 
readily available at the iliac crest, plenty can be removed 
at one attempt, and results of graft incorporation has been 
1 
I 
excellent. Of course, chip grafts are useful to fill up 
small irregular bone gaps and are unsuitable when mechanical 
strength is required. In the latter situation! whole bone, 
either pure cortical or cortico一cancellous, may be used 
instead. The trouble of whole bone grafts is that 
incorporation takes long periods, and incorporation is, as a 
rule, partial. With the advent of microsurgical techniques, 
joining vessels of small sizes (i.e. around litim in diameter) 
and free vascularized bone transfer, has become a reality. 
This form of bone graft gives a replacement with varying 
degrees of viability. When vascularization is perfect the 
transferred bone is enjoying perfect blood supply and the 
• I 
cells will survive, so does the bone. Therefore the graft 
behaves just as if it has changed its original site, and its 
incorporation into the recipient bone becomes something that 
is equivalent to fracture healing (1)• 
Although bone gtafts (autologous bone) have been 
removed in different bone operations fc^ r variable needs • it 
.丨 • 
is still an extra procedure that requiires time and produces 
I , 
, 1 • 
another site of post-operative pain, irl spite of the usual 
plaesent results. Explorations on artificial bones have 
therefore long started. 
Homologous (allogenic) bone transplantation (from other 
human donors, normally after deep freezing in the bone bank) 
is associated with inherent immunological defense reactions 
specific to the individual together with diminished 
functional capacity and various risks (blood group 
incompatibility, danger of hepatitis). According to recent 
safety regulations, this type of transplantation will in 
2 
future be subject to considerable limitation and increased • I 
costs. ！ 
In heterologous bone transplantation (animal bone 
regeneration is usually practically impossible as a result 
of strong iininunological defense reactions involving the 
different types of bone protein. This is particularly true 
‘ i 
for the hitherto only partially deprot，inized bone grafts. 
(in the well-known «Kiel bone graft» there is still 30% by • ] 
weight of collagenic skeloprotein present)• Clearly, the 
best type of graft which one can use in replacement for 
skeletal defects is autograft, which is known to be well 
accepted, serves as a scaffolding for bone ingrowth, 
stimulates healing and some live cells. Unfortunately, the 
supply of autografts are limited. 
Bone graft to fill bone gaps remains a straightforward 
concept, but the dilemma is obvious. The strong graft gives 
strength but does not survive. The weak graft gets 
incorporated readily but does not withstand stress. The 
artificial bone may have all the good properties but it does 
not readily incorpoirate• The ideal graft may be that one 
which maintains its viability through vascularization, thus 
becomes osteoconductive as well as osteoinducitive through 
its cellular activities. This graft when used, solve a lot 
of problems but is technically demanding and perfection is 
very much wanted but not easily attained. 
Nowadays, Tricalcium phosphate and Hydroxyapatite 
become the hot topic. A lot of research have been done for 
these bone substitute. Some of them utilize rabbits for 
I 3 
；！ 
• 丨 • 
animal study, but they only created a hole with 0.3 cm in 
diameter. They also suture the periosteum back. Their 
conclusion are 七hat,. Tricalcium phosphate and Hydroxyapatite 
may be used for refill hall or gap and there is practically 
no limit on size and quantity. There is no need to sacrifice 
normal structures and there is no donor site morbidity. 
Besides calcium phosphates, a number of other ceramics 
have been considered as implant materials. Since they have 
not found a widespread use, we will only briefly mention 
animal experiments with these materials. They are : calcium 
sulfate (plaster of Paris), calcium carbonate, calcium 
fluorapatite, calcium aluminate, and calcium phosphate 
magnesium aluminate. 
Calcium Sulfate 
Gypsum (CaSO^) was the first ceramic to be evaluated as 
replacement for bony tissues. The most comprehensive reviews 
have been given by Peltier who concludes that plaster of 
Paris can be used safely and conveniently in wide variety of 
bone defects. Absorption of the material occurs fast and 
within a few weeks it is resorbed to a large extent and 
regularly replaced by bone. Degradation is probably not 
cellular, but mainly a simple physicochemical dissolution of 
the relatively soluble calcium sulfate salt. Clinical 
experiments have been widely performed. It is generally 
agree that the material is very tissue tolerant and no 
foreign body reactions have been reported. In many cases 
resorption proceeds too fast, and it isj suggested that 
inclusion of slow resorbing polymers could reduce the ‘ 
I • , 
overall resorption rate. Another solutibn to this problem 
4 
might be given by Dankiewicz and Klimek, who found that it 
is possible to prepare almost equimoral solid solutions of 
CaS04.2H20 and CaHPOA.SHgO since both substances crystallize 
in a monoclinic system. It might be worth investigating 
whether these mixed compounds degrade slower and still keep 
the attractive property that they can be easily formed at 
room temperature like gypsum (2,9). 
Calcium Carbonate 
Calcium carbonates have been sporadically investigated. 
Implant studies showed it to be resorbable and replaceable 
by bony tissues. The mineral aragonite implanted in bony 
tissues of dogs, was degraded after a few months, while 
earlier reports indicate similar behavior with less defined 
calcium carbonates. Since carbonate ions participate in bone 
mineral, it is expected to be biocompatible. Chiroff et al. 
found no encapsulation, but a direct apposition of new bone 
onto aragonite surfaces. The relative ease of preparation 
(it is an abundant mineral, found in nature) might be a 
I 
reason to pursue further studies, but their softness as 
compared with apatites limits potential usefulness to 
nonload""bearing applications, such as healing of periodontal 
defects. 
Calcium Fluorapatite 
Calcium fluorapatite is easy to prepare : it can be 
I 
found in nature as a mineral, large samples can be crystal 
• j I 
grown, powders are easily sintered, and丨no phase transitions 
occur below 1450°C. Only preliminary compatibility studies 
in rats have been reported : Davis et al. finds positive 
results in soft tissue implantation with only thin . 
5 
encapsulation, and Duff reports bone ingrowth in macroporous 
samples with direct bone-implant contact. It is certainly a 
material which deserves more attention and the large 
crystals, either found in nature or in the laboratory, are 
. I 
of particular interest. ‘ 
Calcium Alximinate 
Hentrich et al., Graves et al., and Carvalho et al. 
have developed poly phase ceramics based on CaO and AI2O3. 
Certain combinations of CaO and AI2O3 give various phases, 
each having its own resorption characteristics. For example, 
j 
a phase 12CaO.7AI2O3 will slowly hydrolyze, which results in 
a complete impregnation of a poly phase! ceramic, containing 
such a hydrolyzable phase. Single phase implants however are 
not altered. Implants in rats have shown no toxic effects. 
The development of calcium phosphate implants, however, has 
limited interest in such materials. 
Calcium Phosphate Magnesium Alumlnate 
McGee and Wood fired an equimolar mixture of Ca3(PO^)2 
and MgAlsO^ and prepared a strong hard white material 
showing whitlockite and MgAlaO^ diffraction patterns. No 
degradation (after a limited time of months) was found. 
Later Majling and Hanic produced single crystals. The same 
conclusion as for the preceding material pertains here since 
with the availability of ceramics based on bone minerals 
there is no need to pursue materials with foreign components 
anymore, unless they have specific properties(9). 
Bioactive glass as a bone substitute 
Bioactive glasses are materials to which bone can bond 
6 
chemically. The glass is bonded through a series of 
dissolution and ion exchange reactions at its surface. The 
net result is the formation of a reaction layer consisting 
of a Ca,P—rich surface layer and a Si—rich subsurface layer. 
The bone is firmly attached to the Ca,P-rich surface of the 
glass. In addition to their bone bonding ability the glasses 
also conduct the growth of new bone along the surfaces and 
therefore have potential as synthetic bone grafts. The 
mechanical test shows that bone bonds firmly to the glass 
within 2 months in rabbit tibia. During a 3 months 
implantation period in sheep it was found that both 
cylinders and granules were well integrated in the femur. 
However, also empty control holes were filled with new bone. 
On the contrary,in the sheep mandibular jaw new bone did not 
fill empty holes nor holes with glass cylinders. Holes 
filled with granules, however, were nearly completely filled 
with new bone. Bone attaches firmly by chemical bonding to 
the bioactive glass S53P4. The glass has, especially when 
used as granules, a strong osteoconductive effect. Thus, it 
is interesting as a synthetic bone substitute(1). 




Bone grafting research has been dynamic and 
challenging. On the clinical side, it leads directly towards 
an improvement of clinical results and offers solutions to 
traditional problems, on the research side, innovative ideas 
are plentiful and continue to attract 七he best imaginations. 
One of the recent experiment work on bone grafting, for 
instance, made use of a vascularized periosteal wrap into 
which cancellous bone chips were laid. The presence of the 
periosteal wrap produced substantial new bone formation 
7 
which was far more superior to having the cancellous chips 
buried in muscle alone. 
1 
Degradable, or potentially degradable, ceramics 
consisting of salt other than calcium phosphates have not 
been studied extensively, an exception being calcium 
sulfate. This material has the great advantage for the 
clinician that it can be formed during an operation by 
simply mixing a powder and a liquid. If further research 
could eliminate the drawback that calcium sulfate resorbs 
too fast, it might be a very useful clinical implant 
；丨 
material. Calcium fluorapatites can be obtained at least as 
easy as hydroxyapatite, and the limited animal studies show 
similar biological properties. Since it is a component of 
bone, one would not expect otherwise. It certainly deserves 
more attention, especially if one considers the ease of 
preparing large single crystals. 
In particular, calcium phosphate ceramics 
[hydroxyapatite (HA) or tricalcium phosphate (TCP)] have 
received wide attention. Their chemical properties resemble 
those of bone minerals. However, they have a relatively low 
mechanical strength(10,14,15,19). Their clinical application 
is limited to nonweight-bearing areas or to bone cavities. 
From a physicochemical point of view, the optimum firing 
temperature for HA is between 1100°and 1150° Jarcho 
described HA specimens fired at higher temperatures as 
showing increasing grain growth and opacity, although the 
composition determined by roentgenogram diffraction was 




In a recent study using a rabbit tibia model, Shimazaki 
and Mooney(1985) compared bone regeneration into coralline 
hydroxyapatite (HA) and Tricalcium phosphate (TCP) implants. 
The volume fraction of bone was greater in the coralline HA 
implants at both 3 and 24 weeks after implantation. This 
reference was attributed to the high degree of uniformity in 
pore diameter and interconnecting pores of the coral—derived 
HA, which permitted rapid vascular invasion and sustained 
I 
bone ingrowth. The larger pore size of the HA also 
contributed to the greater bone regeneration. At 24 weeks, 
an average of 46% of the volume of the TCP implants had 
biodegraded. 
Eggli et al(1988), investigated the histophysiology of 
. implant degradation, hydroxyapatite and|Tricalcium phosphate 
cylinders with a diameter of 3 mm were Implanted in the 
cancellous bone of the distal femur and the proximal tibia 
of 15 New Zealand White rabbits for up to six months. All 
implants had homogeneous pore distribution and a porosity of 
60%, Ceramics ..with a pore size range of 50 —100 urn and 200— 
4 00 urn were compared. Morphometric analysis showed that up 
to 85.4% of the originally implanted tricalcium phosphate 
was degraded after six months, whereas the volume reduction 
of the hydroxyapatite was only 5.4% after the same period. 
Within the first months bone and tissue ingrowth and implant 
resorption occurred at a higher rate in the smaller pored 
tricalcium phosphate than in the larger pored material. 
Hydroxyapatite cylinder with small pores were totally 
infiltrated by bone or bone marrow after four months, 
whereas in the larger-pored hydroxyapatite implants tissue 
I 
did not penetrate all pores after six months and the amount 
9 
I I 
of bone within the implant was small (7). , I 
An optimum pore size for bone ingrowth cannot be 
definitively identified at present. Controversy over optimum 
pore size exists in the literature. Klawitter reported 
optimum pore size to be 150 um. in contrast, Flatlay et al. 
concluded the optimum pore size to be 500 um (27). 
By far the most popularly trailed bone substitute are 
Tricalcium Phosphate and Hydroxyapatite, so I expect to use 
these materials in my research but in different way. 
I am not going to search the optimum pore size and 
mechanical effect of these two (TCP and HA) materials but I 
only want to know the osteoconductive effect of them. 
‘ j 
In my animal study which I utilized rabbits, the window 
工 created at the shaft of tibia is 0.5 X 1 crn^ , and the 
periosteum was not sutured back. This is to simulate the 
clinical situation wherein the periosteum is usually 
destroyed as in bone loss incurred in traumatic fractures. 
The Tricalcium Phosphate I am going to use is in powder 
form and the Hydroxyapatite in cream form (granulated 
suspension in 0.01 M phosphate^ buffer). The dense form of 
Hydroxyapatite had been shown by K. de Groot, to have not 
degradation after one year. From these kind of form of TCP 
and HA, I only expect to see how much they can work in bone 
healing. 
In summery, the main aims of my study are ； firstly to 
. I . 
i 
I I .1 
' 1 
10 j 
. , I丨 
see how are Tricalcium phosphate and Hydroxyapatite react as 
an osteoconductive in the condition as close to the clinical 
problem compare to the control. Secondly, we can also know 
whether osteoconductive effect of these bone substitute are 
not affected by the wide of the gap. thirdly, by not suture 
back the periosteum, we also want to know whether it will 






CHAPTER 2 LITERATURE REVIEW. 
2 .1 Bone transplants and implant 
2.1.1. Bone graft, implants and their derivatives 
Present knowledge of bone graft surgery encompasses the 
field of bone cell differentiation, the mechanism of 
osteoinduction, and the immunology of allogeneic transplants 
and implants. The international terminology relating to the 
principles and practice of bone graft surgery conforms to 
the� general field of transplantation surgery. The 
terminology, is based on the gnome of the donor and the 
recipient's immunosurvei1lance not only of viable bone 
grafts but also of biochemical components of nonviable 
alloimplants. The term implant applies to nonviable bone 
that has been frozen, freeze-dried, or sterilized by 
irradiation. The term also applies to bone exposed to 
chemical solutions for extraction of antigenic substances or 
for chemosterilization. 
Implant of chemically extracted chemosterilized bone, 
in the strict sense, are not bone but are derivatives of 
bone. 
I 
2.1.1.1. Survival of donor cells ！ 
I 
'I 
• . . J 
A relatively small number of the donor's cells in 
compact bone and a large number of these cells in cancellous 
bone survive autologous transplantation. The proliferation 
of histocompatible cells accounts for the obvious 
12 
superiority of autologous over allogeneic bone for 
transplantation. Autologous osteoprogenitor cells, or 
preosteoblasts proliferate and bridge the gap between the 
surface of donor and recipient. The earliest deposits, 
identifiable either by sex chromatic or by H—thymidine— 
labeling techniques, develop from the preosteoblasts. 
Transplanted osteocytes generally die in response to anoxia 
and injury of surgery. The dead cells disintegrate by 
autolysis and leave empty lacunae. 
Preosteoclasts, t>reosteoblasts, and osteoclasts may 
1 • ‘ survive transplantation. Transplanted osteoclasts may 
1 
initiate resorption of the donor tissue丨丨 but the process of 
resorption depends upon revascularisation. 
2.1.1,2. Osteoclasts 
Observations on parabiosed rate by Buring affirm the 
theory that preosteoclasts and osteoclasts are derived from 
the monocyte-macrophage cell lines. The preosteoclast 
precursor cells originate from blood-borne bone marrow-
derived cells that migrate into areas of bone formation 
generally concurrent with the remodeling of the woven bone 
into lamellar bone. Consequently, the generation of the 
preosteoclasts and osteoclasts first requires transport of 
precursor cells through the blood stream and then requires 
such microenvironinental factors as found in remodeling bone. 
Too few of the donor tissue osteoclasts survive 
transplantation to be identified either in an allograft or 
in a composite bone graft. It is possible that 
multinucleation and osteoclast formation occur only on 
13 
mineralized living bone surfaces. Transplantation of 
cJemineralized allogeneic bone powders induce aggregation of 
foreign body-type multinucleated cells called matrix-clasts. 
These possibly develop by fusion of macrophages and may or 
may not be entirely comparable to osteoclasts. Osteoclasts 
are activated by the parathyroid hormone, osteoclast-
activating factor, and other agents unrelated to foreign 
body giant cell phagocytic functions. The ultimate fate of 
osteoclasts is not known. Fission and recycling along a 




In autografts of embryonic bone rudiments onto 
chorionic allantoic membrane and in transplants of postfetal 
cancellous bone, the tissue circulation is restored by 
formation of microanastomosis. Microanastomosis restore 
circulation, supply nutrients for synthesis of cell 
products, support proliferation of osteoprogenitor cells and 
sustain differentiation of new osteoblasts as well as 
• i 
formation of new osteoclasts. Proliferation occurs in a 
layer of only about 1 mm of the bone tissue of the surface 
of an autograft that is in direct contact with the recipient 
bone bed. Alloimplants revascularize not by microanastomosis 
but by invasion of capillary sprout from the host bed during 
the process of iresorption of the old matrix. 
‘ ！ • 
i丨 
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2.1.1.4. Differentiation of new bone cells by induction. 
The process of recruitment| mesenchymal-type cells into 
cartilage and bone under the influence of a diffusible bone 
morphogenetic protein (BMP) is termed osteoinduction. 
Present evidence for a diffusible BMP is derived from 
observations on transplants, implants, and soluble 
hydrophobic glycoproteins in muscle pouches. The mode of 
action of BMP is not known. Hypothetically, BMP would 
diffuse from the organic matrix of the (konor to cell surface 
! 
receptors of mesenchymal type cells of the recipient. ‘ ’ i丨 
Tangible evidence in support of this hypothesis is lacking 
because immunochemical localization on cell surfaces will be 
possible only when a well—purified BMP becomes available. 
Historically, there are two unresolved diametrically 
opposed theories about the origin of bone cells in postfetal 
life. The first and the longest-held theory is that in 
postfetal life, new bone develops from preexisting bone, 
particularly a population of osteoprogenitor cells 
(preosteoblasts) in periosteum endosteum, marrow reticulum. 
The second and newest theory is that new osteoprogenitor 
cells are recruited by induction of residual mesenchymal 
type cells in marrow reticulum, endosteum, periosteum, and 
even in the connective tissue framework of the surrounding 
muscle. Both theories are correct because in an autologous 
graft new bone originates in early stages from surrounding 
osteoprogenitor cells and later stages from the inductive 
response of the host. 
15 
. I 
Conceptually, the inductive process is regulated by a 
diffusion gradient of BMP. The arguments against the 
osteoinduction concept is the supposition that non specific 
injury can incite proliferation of osteoprogenitor cells and 
generation of bone. A further supposition is that cells of 
regenerating injured muscle may grow into nonbiologic or non 
viable bone implants by osteoconduction alone. Even so 
‘ • I 
preexisting preosteoblasts are sufficient to account for the 
superiority of autograft over alloimplants of bone, the 
evidence of the osteoinduction concept is firmly supported 
by experimental research. In rats, bone cells differentiate 
in postfetal life in implants of either non viable 
demineralized bone matrix or soluble BMP in a diffusion 
I 
chamber in muscle pouch with no possibly contact with 
preexisting bone or significant damage to muscle. Moreover, 
i 
the quantity of new bone is proportionai to the mass of the 
matrix implant or the dose of the BMP. 
The literature on the Biochemistry of BMP and the 
physiology of the mesenchymal cell response is extensive in 
laboratory rodents but are relatively limited in dogs, 
monkeys, human beings, and other long life animals. 
Mesenchymal type cells with a high level of competence to 
\ 
respond to BMP are present in the connective tissue 
framework of muscle, tendon, fascia, subcutis and other 
somatic structures. The same structures exhibit 
insignificantly lower level of competence in long lived 
animals. In human beings, the mesenchymal cell population 
with a level of competence to respond to BMP comparable in 
rodent muscle is found in bone marrow stroma. The muscle and 
other somatic connective tissue mesenchymal cells are 
16 
competent to respond to BMP and produce heterotropic bone is 
easy to observe in animals. That heterotropic bone 
formation is induced by injury to muscle attachments to bone 
and by other regional or local disorders is also commonly 
observed in patients. Infect, the propensity of the muscle 
connective tissues to produce bone is hardly realized and is 
as yet unexpressed for useful purposes for reconstructive 
surgery. This propensity is strikingly demonstrated by an 
extraordinarily wide, but highly specific, variety of 
experimental models. For example, transplants of Urinary 
bladder, HeLa cells, placenta and vaccinia—transformed 
fibroblasts induced muscle mesenchymal type cells to 
differentiate into bone. The biochemical mechanism is 
I 
unknown but clearly develops through epithelial mesenchymal 
cell interaction. 
BMP is a hydrophobic glycoprotein and evokes a cross 
species bone morphogenetic response. Speculation about net 
positive or negative surface alterations, streaming 
potentials, and prizoelectric effects as possible mechanism 
of bone induction are now under intensive investigation by 
research workers all over the world. Whatever the net 
surface charge on an osteoinductive alloimplant may prove to 
have, the matrix of bone transplants have a BMP component 
that distinguishes bone inducing from non inducing systems. 
This component also might be proved by further research to 
account for the capacity of bone to rembdel ih postfetal 





2.!•2. Phases of bone graft incorporation 
The incorporation of autografts and properly prepared, 
biologically active alloimplants of bone occurs in five 
stages. 
Phase 1 occurs within minutes to hours after a surgical 
would and consists of inflammation,and proliferation of 
preosteoblasts and preosteocla曰ts in the recipient bed. BMP, 
along with various degradation products of transplanted 
tissue, initiates chemotactic-directional migration of cells 
toward all exposed surfaces outside and inside the structure 
of the graft. Phase 1 occurs in response to a bone graft; 
the same is true in autologous and allogeneic bone, 
irrespective of whether the donor tissue is living or dead. 
Phase 2 and 3 are contiguous with j^hase 1; they occur 
from day 1 to day 7, and develop after inflammation of the 
surgical injury subsides. Phase 2 and 3 are characterized by 
the response of the recipient bed fibroblast-like 
mesenchymal cqlls to donor tissue BMP. In an autograft, BMP 
transfer and the osteoinductive response are also produced 
by secretions of osteoblasts. In an alloimplant, it is 
supplemented by transfer of BMP from the organic matrix to 
mesenchymal cell surface. The BMP is destroyed by 
autoclaving or irradiation sterilization. The osteoinductive 
response to BMP is blockaded by a Hypersensi七ivity-like 
reaction, and a histoincompatibility immune response is 
observed by infiltration of blood-borne small, round cells, 
plasma cells, and reticulocytes. The blockade appears by the 
third week after a living allagraft and by the fourth week 
, . i 
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after implantation of freeze-dried allogeneic raw bone. The 
blockade is further delayed and the osteoinductive response 
is relatively unimpeded in implants of antigen extracted, 
antolysed allogenic AAA bone. 
i 
Phase 4 consists of osteoconduction and occurs over 
periods of months to years. Osteoconductive depends on 
growth of new bone by extension from a recipient bed. 
Osteoconduction is characterized by ingrowth of spouting 
capillaries and new bone into nonbiologic structures such as 
methyImethacrylate, ceramic, and calcium sulfate or 
denatured biologic structures such as irradiation-sterilized 
bone or autoclaved bone. Osteoconduction is prevented by 
formation of a membrane of fibr^ous tissue between the host 
and donor, but it is promoted by contact compression or 
interdigi^tation of the interstices of the donor and host 
bone structure. In osteoconduction, the structure of donor 
plays a passive role. The process is important and rapid in 
young, growing bones. Osteoconductive is more closely linked 
with osteoinductive processes in the incorporation of 
biologic undenatured resorbable grafts ^nd implants than in 
, 1 
I 
nonbiologic nonabsorbable substances. 丨 
：| 
Phase 5, both autografts and alloimplants gradually 
(for periods as long as 2 to 20 years depending on the 
quantity and shape of the donor tissue) perforin a purely 
mechanical function. Successful autografts, allografts, and 
nonbiologic implants eventually become enmeshed in the 
structure of the recipient bone. Phase 5 is as important as 
the preceding four phases, because by the time the repair 
processes subside, only about 10% of the volume of the donor 
EEIZZIZIZllI] 
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tissue may be remodeled or otherwise altered. Hence, 
nonviable bone (with osteocyte lacunae devoid of cells) 
constitutes 90% of the total mass of a successful cortical 
bone autograft of alloimplant. A small volume (possibly 20%) 
of bone with empty lacunae similarly fills cortical bone of 
I 
some parts of the skeleton in aged normal individuals. 
I ‘ 
t 
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The rate of incorporation is optimum when information 
about the cellular activity of each phase is fed back to the 
preceding phase and transferred to the succeeding phase of 
development. Qsteoinduction may occur without 
osteoconduction-as in osteogenesis in response to secretions 
of uroepithelium-but not in a bone autograft. Osteoinduction 
without donor derived living osteoprogenitor cells occurs in 
alloimplants of demineralized freeze-dried or thimerosal 
(Merthiolate)-fixed bone matrix,in a muscle pouch. Provided 
that contact compression is applied to a fresh allograft, 
osteoinduction and osteoconduction may occur in sequence 
even in the presence of a delayed hypersensitivity reaction. 
Normally, the osteoinductive and osteoconductive phases are 
in a dynamic equilibrium or are closely associated processed 
j 
steadily progressing toward donor tissue incorporation. The 
incorporation of allogenetic bone at a slower rate than 
autologous bone may be attributable to dissociation of 
osteoinductive from osteoconductive phase by delayed 
hypersensitivity reactions. Elimination of the 
osteoinductive stage, as in autoclave-sterilized, and 
一propiolactone—sterilized, or benzalkonium—sterilized bone, 
reduces the rate of incorporation. Thimerol and 
polyvinylpyrrolidoneiodine (Betadine) sterilization 
(unpublished experiments) do n6t extinguish the 
20 
osteoinductive response in rats, but other methods of 
chemosterilization, are more applicable to human bone 
bank(18). 
‘ • i 
Although the experimental evidence for osteoinductive 
is now well established. Knowledge of the biophysical 
chemistry of substrata for expression of bone morphogenetic 
potential is only beginning to materialize. Important 
information is also emerging from observations on 
histoincompatibility reactions that may blockade the 
inductive response more completely in ^luman beings than in 
I 
rats, rabbits, and other experimental animals • 
•丨 • I 
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2.2. Preparation and properties of calcium phosphate 
biomaterials 
The most widely investigated calcium phosphate 
biomaterials are composed of either Hydroxyapatite (HA) 
[Ca^Q (PO4)g(OH)2] or Tricalcium Phosphate (TCP) 
[Ca3(PO4)2], with the latter usually having a - whitlockite 
crystal structure. 
Virtually all current calcium phosphate biomaterials 
can be classified as polycrystalline ceramics since their 
material structure is derived from individual crystals of a 
highly oxidized substance that have been fused together at 
the crystal grain boundaries by high temperature process 
called sintering. In dense calcium phosphate ceramics, the 
most typical processes use high pressure powder compaction 
techniques whereby a calcium phosphate powder is compacted 
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into a given shape in a press to produce a compact, 
frequently called a "green" state, which is then sintered at 
temperatures in the range of from 1100°C to 13 00°C to 
produce the dense ceramic material. Although uniaxial 
compression methods (pressure applied along one axis) have 
been used to prepare small ceramic specimens, most methods 
rely on isostatic compaction whereby pressure is applied to 
a flexible, powder—filled mold from all directions via 
hydraulic systems; this usually generates denser and 
stronger green compacts and ceramics than uniaxial 
compaction(14). 
I 
Another ceramic fabrication method used is hot-
pressing, whereby the powder is pressed and heated 
simultaneously to generate the final ceramic body in one 
step. Another procedure has also been developed that 
involves precipitating the calcium phosphate from aqueous 
solution, and collecting and molding the still wet 
precipitate in a claylike fashion. After drying, the object 
is sintered to produce dense ceramic material, 
2.2.1. Drying and sintering of wet slurries 
Jarcho Micheal et al(1981). succeeded in preparing 
almost 100% dense materials by using a laboratory made 
powder of hydroxyapatite. According to Hayek they fired a 
wet filtered cake, but fired the cake at about 1200°C rather 
than 800°C. Samples with a thickness of about 3 mm, and 
i ‘ 
areas of up to 100 cm2 were obtained. Mechanical strength is 
claimed to be impressive with a compressive strength of up 
to 900 MN/in2 and a fracture strength of 85 MN/in2 rising up 
22 
% 
200 MN/m2. However, Akao at al. have shown that theses high 
I 
values result from their sample shapes, and that the actual 
value for compressive strength is 400 MN/in2. When implanted 
in bones of dogs, bone grew onto the implant surface and 
formed a tight bond with it. No degradation was found after 
6 months, a result confirmed by Boyne who implanted their 
ceramic in surgical periodontal defects of monkeys. A 
similar technique was applied simultaneously by a Japanese 
group who reported similar mechanical, crystallographic, and 
biological results. Very recently Jarcho developed a 
technique to induce a phase transition from apatite to 
-whitlockite by mean of ammoniuin sulfate as initiator. 
Strength was not influenced by this process, but biological 
behavior has not yet been reported. 
The methods used to prepare porous calcium phosphate 
ceramics have been largely guided by the classical studies 
of Klawitter and Hulbert which establistied the minimum pore 
i 
size required (approximately 100 urn) for effective ingrowth 
of bone into porous ceramic structures. The most widely used 
fabrication method consists of homogenizing calcium 
phosphate powders with appropriately - sized naphthalene 
particles, followed by compaction of the mixture to produce 
a green state. Removal of the naphthalene is accomplished by 
sublimation which leaves a macroporous green state whose 
integrity is maintained through the sintering step. Another 
method relies on the decomposition of hydrogen peroxide to 
generate a porefilled structure. A novel hydrothermal 
exchange method for producing calcium phosphate replicas of 
marine coral structures has also been developed coral 
specimens are heated at elevated temperatures and pressures 
23 ‘ 
in the presence of an aqueous phosphate solutions, thereby 
replacing 七he calcium carbonate of the coral with calcium 
phosphate replicas. Depending on the species of coral used, 
bQth HA and TCP materials have been produced in this manner. 
The rational for producing these so-called "rep1amineform". 
Calcium phosphate implants is that their highly organized 
and permeable pore structures may offer advantages, namely, 
fluid circulation and ingrowth, over totally synthetic 
porous materials which have much more random pore 
structures. 
i 
2.2.2. Crystal and chemical factors. 
The calcium phosphate system, although conceptually 
simple, displays a rich and complex wet and thermal 
chemistry that continues to be a very active area of 
research. The precipitation of HA and TCP from aqueous 
solutions is known to involve a complex series of events 
that can be significantly affected by subtle changes in 
reaction conditions or the presence of trace materials and 
the thermal crystal/chemistry of the system is subject to 






since most of the calcium phosphate biomaterials 
currently being investigated use starting materials that 
have been prepared (or manufactured) in aqueous solution, 
and since all involve a high temperature processing step, 
many of the calcium phosphate system can affect the 
composition of these biomaterials. Thus, it is a lack of 
effective understanding and casual preparative techniques or 
the use of common commercially available "Reagent Grade" 
starting materials that has led to a proliferation of 
calcium phosphate biomaterials with variable (and frequently 
nonreproducible) crystal and chemical compositions. For 
i . • 
example, one can take samples of "pure"| HA powder from 
various sources, and process them in identical fashion to / ：! 
� yield calcium phosphate ceramics with greatly differing 
compositions (relative amounts of HA and TCP) and mechanical 
properties. 
A detailed discussion of the eccentricities of the 
calcium phosphate system as they pretend to the preparation 
of implant materials is beyond the scope of this review. 
However, rigorous control of implant composition, while not 
necessary for biocompatibility, is essential to achieve 
predictable in viva results, pairticulairly with regard to 
bioresorption characteristics. 
2.2.3. Factors Governing Bioresorbability• 
. i 
The factors that determine the rate and degree (if any) 
of bioresorption of calcium phosphate bioceramics remain an 
area of controversy and confusion. Some bioresorb and some 
do not; some do partially, some too fast, some too slow; 
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some do not initially but do later on, and so on. An 
understanding of this diverse bioresorbably behavior can be 
gained by considering these substances from two points of 
yiew their crystal/chemical composition and 七heir structure 
as "materials". Additionally, the assumption is made that 
two different biologic resorption pathways exist-solution 
irrediated processes (the implant dissolves in physiologic 
solutions) and cell-mediated processes (phagocytosis)• 
As mentioned earlier, most of the implant materials 
currently under investigation are composed of HA or TCP, or 
combinations of the two. It is generally known from earlier 
studies that TCP dissolves more rapidly than HA in a variety 
of solvents. In reference to biologic material, the relative 
dissolution rates in buffered lactic acid of human dental 
enamel and a dense HA ceramic (reported to be nonresorbable 
as an implant material) have been examined. Dental enamel / 
dissolved ten times faster then the HA ceramic on a weight 
basis; when the results were normalized丨for surface area, 
both materials were found to dissolve at identical rates. 
丨  
Another study compared the relative dissolution rates 
of dense HA and TCP ceramics in buffered acid (pH 5.2;0.4M 
lactate) and buffered basic (pH 8.2;0.05M edetate) media. 
Both materials were prepared by similar methods, both were 
well characterized as 100% pure and 100% dense and both had 
very similar ceramic microstructures• The TCP ceramic 
dissolved 12.3 and 22.3 times faster than the HA ceramic, 
respectively, in the acid and basic media. Thus, among HA-
TCP ceramics with similar material structure, differing 




chemical preparative techniques), bioresorption rates should 
be directly proportional to the TCP content of the ceramics. 
Consistent with this are the in vivo results obtained with 
two different porous implant materials, both of which were 
prepared by similar methods (naphthalene pore formation) but 
from different calcium phosphate powders. One of these 
materials is composed piriinairily of TCP and is bioiresorbable, 
while the other is composed mainly of HA and has no 
significant tendency to bioresorb even after prolonged 
(longer than one year) periods of implantation• Additional 
evidence has also emerged from in vivo studies (dog tibia) 
comparing porous calcium phosphates of various compositions. 
It was found, for example, that TCP implants resorbed much 
more rapidly than tetracalcium phosphate implants of siinilai: 
structure. Despite evidence which clearly points to the 
importance of chemical composition in determining calcium 
phosphate bioresorption rates, supposedly guiding statements 
to the contrary can still be found in the current 
literature. 
Material factors alone can affect the bioresorbability 
of these (or any) implant materials and in some cases may 
completely override the chemical considerations discussed 
above. Surface area is, of course, a major factor in 
determining dissolution rates of any solid material, and in 
I 
fact, most such rates are expressed in terms of weight 
dissolve per unit surface area exposed. In dense calcium 
phosphate implant materials, simple in vitro dissolution 
assays can be predic七ive with regard to bioresorption., but 
undeiTstarKaing the materials factor which govern the 
bioresorption rates of porous calcium phosphates is a far 




more difficult problem. The numerous porous calcium 
phosphate ceramics currently being investigated frequently 
have differing degrees (and sizes) of macroporosity (pores 
greater than 100 um) purposely introduced for tissue 
ingrowth, different microporosity (pores less than 5 um) 
which results from a particular fabrication process, 
different type of pore interconnectivity and organization, 
and so on. Since we know that it is extremely difficult to 
get meaningful and reproducible quantitative dissolution 
rates from*porous materials of the type in question, in 
vitro comparisons might well be misleading(9). 
Most porous calcium phosphate implants currently being 
investigated have been fabricated to have interconnecting 
I 
macropores in range of from lOO to 400 um in order to meet 
the requirements for bone ingrowth which emerged from the 
studies of Klawitter and Hubert. At present, however, there 
is no in vivo evidence to suggest that the highly organized 
macropore structure of the coral derived HA is better, with 
regard to bone ingrowth and bioresorption, than the random 
pore structures of the more easily prepared totally 
I I synthetic porous implants. In order to establish such \ 
1 • 
evidence, competitive experiments between materials will be 
required incorporating quantitative measures of ingrowth and 
reabsorption of the type being developed by Holmes, this 
method uses computer—assisted analysis of scanning electron 
microscope backscattered electron images in order to measure 
accurately the amount of implant material, bone, and soft 
tissue in serial sections of implant sites. 
One interesting and possibly guiding suggestion, put 
28 
forth by de Groot (1982), is that it is actually the 
micropores in these structures which determine the rate of 
bioresorbability. In ceramic structures, micropores (usually 
less than 5 uiti in size) are sometimes found more or less 
uniformly distributed within the gross polycrystalline 
structure and are frequently localized at the grain 
boundaries which connect the individual crystallites. It is 
quite possible that this microporosity could aid in 
bioresorption by causing microscopic "break—up" secondary to 
solution mediated resorption. Thus, partially dissolved 
materials could slough off individual crystals or fragments 
that are sufficiently small to allow for aggressive cell 
mediated removal (phagocytosis) • Evidence in support of the 
above hypothesis has been the observation of multinuclear-
type cells in close proximity to bioresorbable calcium 
phosphate implants. In some cases, ceramic fragments were 
indeed found to be present within vesicles of these cells. 
Should this theory of microporosity prove to be 
correct, it would offer the possibility of adjusting . 
bioresorption rates by purposely introducing degrees of 
microporosity. Taken to an extreme, ho\^ever, a material 
which relied too heavily on aggressive|phagocytosis for 
bioresorption would, out of necessity, cause an acute or 
chronic inflammatory response. 
Despite "limited knowledge of the factors which control 
the bioresorption of calcium phosphate implant materials, it 
is clear that both chemistry and material structure play key 
roles. Consistent with the preceding discussion, the 
following guiding rules appear justified : (i) high density 
29 
implants, be they HA, TCP, or mixtures of the two, will show 
little tendency to bioresorb due to their small surface 
area; (2) porous TCP implants will resorb much more rapidly 
than porous HA implants of very similar structure; and (3) 
i 
within limits, the present of microporosity may be a factor 
in promoting the bioiresoirption process. 
2-2.4. Mineral composition 
Hydroxyapatite and tricalcium phosphate release calcium 
I ‘ ‘ 
I and phosphate ions during their bioresqrption. Degradation 
I 
of the implants occurs by either simple dissolution or cell-
mediated processes (osteoclastic phagocytosis)• The rate of 
biodegradation depends on its crystal/chemical composition, 
its density, its exposed surface area, and its proximity to 
soft tissue versus bone. Previous studies suggest that 
tridalcium phosphate dissolved much more rapidly than 
hydroxyapatite, especially when it is placed in soft 
tissues. 
The rate of bioresoption should ideally correspond to 
the clinical needs of any given case. The biologic half—life 
of a calcium phosphate implant would preferably be longer in 
those setting where some mechanical strength is required and 
shorter in those situation in which it merely serve as a 
spacer. Eventually all implants should completely resorb, 
thereby permitting gradual remodeling of the ingrowth bone. 
Unfortunately, none of the currently available implants have 
standardized chemical and structural properties that allow 
for precise prediction of their rate of biodegradation. 
30 
Future techniques in implant fabrication should solve this 
problem. 
2.2,5. Mechanical properties of calcium phosphate ceramics 
The principal limitation of calcium phosphate implant 
materials is their mechanical properties. Like most 
ceramics, these materials are quite brittle, have low impact 
resistance, and relatively.low tensile strengths. A 
comparison of the ranges of mechanical properties observed 
with calcium phosphate ceramics versus those currently used 
metallic materials, as detailed in Table 1, would appear to 
preclude their use as hard tissue prosthetic materials. This 
is true of currently used prosthetic devices, such as bobe 
plates, screws IM rods, and even such short span objects as 
free—standing tooth implants. However, if one concept "bone 
graft substitutes," it is possible to restore their 
• I 
credibility, to a certain degree, with regard to 
biomechanical suitability. Most porous calcium phosphate are 
being investigated as homograft or autograft substitutes or 
extenders with the hope that they will serve as a scaffold 
for repair, and then resorb; the strength of these porous 
materials are more or less comparable to cancellous bone. 
Dense hydroxyapatite ceramics, in the form of coarse 
1 I 
particles and in simple plug forms, are being investigated 
I 
！ . 
as materials for augmentation and maintenance of bone 
contour in potentially atrophic areas such as the edentulous 
alveolar ridge,, their function is to maintain surrounding 
bone rather than to fulfill a,rigorous biomechanical 
requirement. Thus judicious used of these materials, with 





offers the promise of generating useful new hard tissue 
prosthetics(8,10,30)• 
Table 1. The Mechanical Properties of Bone and Metallic and 
Calcium Phosphate Implant Materials 
Compressive Tensile Modulus 
Material Strength Strength 
(10 Psi) (10 psi) (10 psi) 
Bone 
Cortical bone 20 lo.o 2 
Cancellous bone 6-9 0.5 -
Metals I 316 L Stainless - 80-145 30-40 
Cor-Cr alloy - 97 
Titanium 一 5 0 1 6 
Calcium phosphate 
Porous 1-10 0.36 -
Dense 30-130 10-28 5-15 
• I • I 
I . 
I • ’ 
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2.2.6. Basic Biologic Profile of Calcium Phosphate Implant 
Materials. 
As a result of accelerated efforts toward developing 
calcium phosphate implant materials of various types, an 
increasing amount of information is becoming available, A 
basic and highly attractive biologic profile has emerged 
which includes a lack of local or systemic toxicity, lack of 
inflammatory or foreign body response, an absence of 
intervening fibrous tissue between implant and bone and most 
remarkably, the apparent ability to become directly bonded 
to bone by what may prove to be natural bone cementing 
mechanisms. Since this profile has been observed with 
implant materials of varying chemical composition and 
material structure, it appears, at present, that this highly 
attractive profile is in fact generic to all calcium 
phosphate implant materials, 
A possible explanation lies in the chemical nature of 
these materials; all are composed mainly of calcium and 
phosphate ions, the same ions v^hich make up the bulk of 
natural bone mineral. Because of this, these materials, when 
implanted in bone, are capable of participating in calcium 
phosphate solid solution equilibria at their surface. The 
requisite calcium and phosphate ions needed to establish 
these equilibria may be derived from the implant or 
surrounding bone, or both. It would be Expected that the 
composition of any solids deposited on the surface of these 
implants would largely be determined by：the surrounding .pa 
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physiologic media, and of course, in bone, this medium would 
ultimately produce calcium phosphate solids in the form of 
biologic apatite(2,8). 
Indirect evidence supporting this hypothesis is 
available from numerous in vitro studies describing the 
effects of various seed materials on the precipitation of 
calcium phosphates from aqueous media. Additionally, some 
direct evidence for this bone mineral coating of calcium 
phosphate implants will be provided in the discussion on 
"bone-bonding". The net effect is that all calcium phosphate 
implant materials will become coated with a microscopic 
layer of biologic apatite shortly after implantation in 
bone, and it is from this layer that the generic biologic 
profile of calcium phosphate implants is derived. 
The histologic sequelae associated with implantation of 
non-porous calcium phosphate materials in bone can be 
characterized as representing normal bone healing processes 
on and around the implant. At the interface of both dense 
and porous materials, bone is usually found to be deposited 
directly on the surfaces without the presence of an 
intervening fibrous tissue capsule. Normal calcification 
also takes place at the implant sites. In one study of dense 
HA implants placed in surgically-created defects in dog 
femurs, the implant sites were examined versus adjacent old 
bone sites foe calcium and phosphorous content and Ca/P 
ratios with the electron microprobe usiiig point counts, line 
ratemeter scans and pulse images. Normal calcification 
processes were observed iimnediately adjacent to the 
implants, as evidenced by increasing Ca/P ratios (from 1.50 
34 
at one month to 1.62 at six months) and increasing calcium 
and phosphorous concentrations; at six months, 
mineralization within the implant sites was comparable to 
that of surrounding bone. Similar observations have been 
made by others using less quantitative techniques such as 
microradiography and energy dispersive analysis. The 
• I 
described general pattern of healing and mineralization also 
holds true on the outer surfaces and pores of porous calcium 
phosphate implants; however, these processes sometimes 
become retarded as tissue infiltrates the inner pores of 
these materials. 
The lack of inflammatory liabiliti^es of calcium 
I 
phosphate implants is perhaps best demonstrated by the fact 
I 
I • 
that even in cases of gross failure, untoward histologic 
responses are not observed. Thus, in a dog study to 
determine the suitability of a porous TCP implant for use in 
spinal fusion, most of the implants became crushed and/or 
dislodged shortly after implantation (three to six weeks), 
indicating the mechanical unsuitability of the material for 
this use. Histologic examination of the implant sites 
nevertheless revealed an absence of inflammatory or foreign 
body response to the material(2,4). 
One of the most unique and potentially valuable 
• features of calcium phosphate implants is their apparent 
ability to become directly bonded to bone. Early animal 
experimentation centered around the use of porous calcium 
phosphate implants, based on the rationale tAat these porous 
structures would allow for bony ingrowth and therefore, 
mechanical stabilization of the implant. Gross or even 
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miciTQscopic examination of these porous implant sites, 
therefore, did not readily reveal this bone-bonding 
phenomenon. In conjunction with a scanning electron 
microscopic study of fractured samples of porous TCP implant 
sites, however, Driskell et al. first noted "the fracture 
lines propagated through the bone/ceramic interfaces". and 
concluded "the evidence suggests that a chemical bond exists 
between the calcified tissue and the ceramic". With the 
initiation of studies using dense implant materials, it 
became grossly apparent that calcium phosphate implants 
became strongly bonded to surrounding bone without benefit 
of a "mechanical interlock. 
This ability of bone to bond directly to the surface of 
calcium phosphate implants has now been observed by numerous 
investigators using a variety of materials and animal 
models. Qualitatively, the bonding is manifested by the 
inability to remove even dense calcium phosphate implants 
from surrounding bone without ether breaking the implant or 
the bone； rarely does separation occur at the interface. 
Quantitative measurements of the strength of this bond 
between implant and bone have not been reported, but they 
may be similar to the bond form between bone and bioglass, a 
novel calcium and phosphate ion leaching glass that has been 
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Although the exact chemical composition of the "cement" 
I 
that bonds these implants is not known, some information as 
to its nature has emerged from the electron microscopic and 
electron optical observations of several investigators. The 
first evidence of the bonding zone (and gross evidence of 
bonding) appears to be concurrently with the first 
appearance of acellular bone matrix from differentiating 
osteoblasts. At this point, in decalcified sections prepared 
for electron microscopy, the implant appears to be covered 
‘ s . with a narrow (3 to 5 um wide) amorphous electron dense bond 
with no distinct structural details. Needle-like clefts were 
present in the amorphous layer suggesting probable removal 
of minerals during decalcification. Between this amorphous 
zone and the cells, loosely arranged collagen bundles were 
observed. 
Electron microscopic examination of undecalcified 
"early bonding" sections, as reported by one group of 
investigators, revealed that this amorphous zone was 
calcified with plate-shaped bone mineral crystals which had 
deposited directly and irregularly on the surface of an 
hydroxyapatite implant. Another group, using a combination 
of electron microprobe, electron diffraction, and electron 
j 
microscopic techniques, also reported this bonding zone to 
be calcified, but observed the bone mineral crystals 
deposited in an orderly perpendicular palisade array 
directly on the surface of an hydroxyapatite implant. The 
discrepancies between these reports are quite likely due to 
differences in sample preparation techniques(2,8). 
As the implant site matures, the bonding zone shrinks 
I 
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in width until, after several months, it is confined to a 
narrow band (approximately 500 to 2000 A) between the 
implant and normal-appearing bone. Electron microscopic 
examinations of decalcified sections revealed this band to 
be composed of the same amorphous "ground substance" 
observed at earlier healing periods, while undecalcified 
sections revealed the band to be mineralized, with the 
crystals of the bonding zone blending into those that were 
deposited in a normal longitudinal fashion on adjacent 
collagen fibers(12). i 
Based on these observations, the bone bonding substance 
observed on the surface of these implants is very similar in 
character to natural bone cementing substance, which has 
been characterized, as amorphous in structure, heavily 
mineralized, and rich in mucopolysacharides. Detailed 
histochemical studies are required to farther characterize 
this novel bonding zone. 
The lack of local or systemic toxicity is also due to 
the chemical nature of these materials because they can only 
release calcium and phosphate ions. The fate of this 
released calcium and phosphate has been the subject of 
study, particularly with regard to bioresorbable implants. 
Analysis of serum and urine calcium and phosphate levels 
• carried out in conjunction with implant studies of a 
bioresorbable TCP material implanted in puppies (palate) and 
dogs (orbital, iliac, mandible, SC, IM, femur, spine) and 
with a nonresorbable HA in dogs (alveolus) produced normal 
results. In some of these studies, tissue pathology on major 
organs was performed, including fine detail kidney 
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radiography, and no abnormalities or pathological 
calcification was noted(2). 
I 
A study of a bioresobable TCP in rabbits (calvaria), 
however produced normal serum calcium and phosphate levels 
but somewhat elevated urine level of these substances. This 
same rabbit study used radiolabeled (Ca) implant materials 
and various areas (tibia, liver, skin, brain, heart, kidney, 
intestine, and lung) were examined for accumulation of 
labeled calcium at six months postimplantation. Only the 
tibia was found to have measurable quantities of labeled 
calcium, thus indicating that implant-derived calcium was 
accumulated only in the relatively nonexchangeable pool of 
bone calcium. The results of these studies point to the 
conclusion that calcium and phosphate derived from these 
implants enter the body pool and are utilized (or removed) 
in a normal fashion. 
i 
The factors which govern the rate of healing, bone-
bonding, and indeed the efficacy of calcium phosphate 
implants are similar to those which govern the "take" of a ‘ 
bone graft. Initial stabilization is a prime factor, with 
many investigators noting the need for tight fixation of the 
implant to adjacent bone as a prerequisite for effective 
healing. Migration of the implant from a bony site into 
adjacent soft tissue, while obviously undesirable, does not 
• • ！ • 
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produce inflammatory responses since these materials are 
also well tolerated by soft tissue, wherein they are 
sequestered by a quiescent fibrous tissue capsule. 
The osteogenicity of calcium phosphate implants has 
also been the subject of some investigation. Although it is 
not uncommon to read statements that these materials may 
stimulate osteogenesis, their drigins are most likely due to 
high biocompatibility of the calcium phosphates relative to 
other materials. Examination of these materials in 
traditional bone induction models, however, produce negative 
results. In one milipoire chamber study, a dense HA implant 
material, in the form of plugs or particles admixed with 
homopoietic marrow, was compared with control chambers 
containing marrow alone. After six weeks of implantation, 
more of the control chambers contained newly formed bone 
i! 
(90%) than did the HA—marrow—containing chambers (35%)• 
Subcutaneous implantation of a porous TCP materials in rats, 
versus the same material coated with calcitonin or 
autogenous marrow revealed that bone formation took place 
only in the marrow coated implants, thus indicating the 
material, either alone or coated with calcitonin, had no 
bone inductive effect; it was noted, however, that the 
material was an excellent vehicle for osteogenic 
inarrow(21, 27). 
Various surgical models have been used to investigate 
calcium phosphate implants with many of them using 
autografts and/or empty defects as controls. Autogenous 
material consistently has outperformed calcium phosphate 
implants with regard to histologically determined healing 
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rates in such areas as periodontal lesions (dog), spinal 
fusions (dog) and segmental replacements (rabbits)• in a 
study designed to determine the time required to effect bony � 
bridging of rabbit tibia lesions, for example, a porous TCP 
material in granular form was compared with autogenous 
cancellous bone as well as mixtures of the two. The 
autograft effected bridging at four to six weeks, the 
1 
ceramic at 14 to 16 weeks, and a 50/50 mixture of the two at 
six weeks. While this study revealed the superiority of the 
autogenous material, the results clearly point to using the 
material as an autograft extender. 
In many cases, empty control defects have been found to 
repair more rapidly than calcium phosphate implanted 
defects. This observation has been in fairly consistent one 
in investigations using porous forms of calcium phosphate as 
the implant material. For example, in one study evaluating a 
porous nonresorbable HA implant material in surgically 
created periodontal defects in dogs, the empty control 
defects were completely filled with new bone after 16 weeks, 
but the porous blocks of HA in the experimental sites still 
contained significant amounts of proliferating fibrovascular 
tissue, other investigators, using a porous particulate 
] i 
bioresorbable TCP implant in essentially the same model 
obtained similar results. In contrast to these findings, 
surgically created periodontal defect implant sites 
containing dense HA implants in particulate form appear to 
allow for healing rates that are more or less comparable to 
those observed in empty controls; similar findings of 
comparable healing rates with empty and implanted (dense HA 
particles) sites have also been reported for femur defect 
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models. 
A possible explanation for this difference in 
histologically observed healing rates between dense and 
porous calcium phosphate implant materials lies in the 
nature of the porous materials,. All of them, either from 
marine coral or totally synthetic, impose upon infiltrating 
bone and precursor fibrovascular tissue an unnatural pathway 
that must be followed if the porous implant is to become 
fully invested with bone. Since bone is a tissue that is 
notorious for proliferating and remodeling according to its 
own overall biomechanical dictates, it would be expected 
that it would travel these unnatural p0re pathways with some 
reluctance. Thus, unless a porous calcium phosphate implant 
1 ‘ . 
material is bioresorbable, with resorpt^ion rates closely 
matching tissue infiltration rates, it would be expected 
that healing within the porous ceramic matrix, as evidenced 
by the ultimate appearance of mature bone, could be slower 
than an empty defect. Additional evidence in support of this 
is a study wherein the calvaria of rabbits were implanted 
with porous blocks of a bioresorbable TCP material. Twenty-
four hours prior to sacrifice (three months), the animals 
were injected with radiolabeled calcium. Radioisotope 
analysis revealed that the uptake within the porous implant 
was approximately one tenth that of surrounding bone; at the 
periphery of the implant, however, the rates of uptake were 
about one half that of surrounding bone. 
In contrast to porous implants, implant sites filled 
with dense, impervious calcium phosphate particles far less 
restrict investing tissues which can then grow over and 
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around the particles according to their own dictates, since 
each discrete particle is capable of undergoing a certain 
degree of motion within the developing bone matrix, dictated 
by surrounding tissue, far less interference with normal 
bone remodeling patterns would be expected. Conceptually, 
this ability of dense calcium phosphate particles to move 
within the implant site could pose problems of gross 
migration or extrusion from the site, but in practice, the 
initial blood clot appears to be sufficiently adhesive to 
maintain the particles within the defect at early periods 
postimplantation; at later per:iods, as a result of the bone-
bonding at the interface of the particles, the restored site 
appears to function as a composite unit with no evidence of 
particle movement, and the strength of such composite units 
can exceed that of normal bone(14). 
/ 
Although calcium phosphate implants do not induce bone 
formation in the traditional sense, th^y do sometimes 
display bone growth "guiding" properties, causing bone to 
I . 
grow into areas that it would otherwisfe not occupy, this 
property has been characterized by various individuals with 
terms such as "osteoconductive" and "osteophilic". Thus, in 
a series of controlled experiments reported by Ferraro, 
surgically created defects were made in the orbital rims, 
mandibles, and iliac crests of dogs. When left unfilled, 
only minimal evidence of any spontaneous repair of the 
various defects was observed during periods of up to one 
year. When similar defects were filled with porous 
bioresorbable TCP implants, however, total growth of bone 
across the prosthesis was observed one year postimplantation 
with bone being present from one bone-prothesis interface to 
43 , 
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the other; some of the resorbable implant was noted to be 
still present at this time. Mors and Kaminski, evaluating a 
porous bioresorbable TCP block implant in surgically created 
cleft palates in beagle puppies, noted greater evidence of 
repair in the implant sites than in empty control defects; 
additional, no interference with normal growth patterns was 
observed. Experimenting with this same porous material, 
other investigators have noted that bone could be made to 
grow above original cortical bone levels by placing the 
implant material so that it partially protruded from 
surgically created defects. For example, bone was found to 
grow laterally from the shaft of dog femurs up to 7.5 mm 
within the ceramic while control defects similarly filled 
with Gelfoam, a gelatin—based hemostatic, showed lateral 
bone growth of only 4 mm. Similar bone augmenting capability 
has been observed with dense particulate HA implants in 
conjunction with human clinical study. 
2.2.7. Osteoinduction 
. I 
There is no conclusive evidence that any of the porous 
calcium phosphate biomaterials are osteoinductive. Most are 
considered osteoconductive, that is, allowing for bone 
ingrowth from an osseous bed. No bone ingrowth will occur if 
the implant is inserted into muscle or subcutaneous tissue. 
There also may be a limit to the rate and depth of bone 
• I ‘ 




Modifications of the "osteoconductivity" theme are the 
observations of one group that calcium phosphate implants 
underlying articular surfaces can affect the nature of 
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overlying reparative cartilage. Surgically created full-
thickness cartilage bone defects of the wieght—bearing 
surface of the lateral femoral condyles of rabbits were 
implanted with porous blocks (4x4 mm) composed of several 
different materials (titanium dioxide, aluminium oxide and 
hydroxyapatite)； empty defects were used as controls. Only 
the hydroxyapatite implant sites demonstrated consistent 
regenerative healing of hyaline articular cartilage; 
fibrocartilage was formed over the other implant materials 
and controls. Several investigators have noted that 
hydroxyapatite implants are able to prevent postextraction 
alveolar ridge resorption in much the same manner as do 
autogenous tooth roots. When placed either sub- or 
perginggivally in fresh extraction sockets of dogs, these 
implants become firmly ankylosed via the bone-bonding 
phenomenon while maintaining and even increasing the hight 
of surrounding bone(15). 
. In contrast, when the same implants are coated with 
gold, they become sequestered and exfoliate from the implant 
site. Although several other types of materials have been 
reported to retard postextraction alveolar ridge resorption, 
including vitreous carbon and polymethylmethacrylate, 




CHAPTER THREE - MATERIALS AND METHODOLOGY 
I . ； 
3.1. Animal study 
3.1.1. Animal selection 
• Criteria for admission to the study, were rabbits age 
between 26-31 week. 
3.1.2. Materials 
Tricalcium Phosphate used was in powder form 
Hydroxyapatite used was in granulated suspension 
3.2• Methods 
3.2•1. Operation. 
Forty rabbits, weighing between 3.2 and 4.4 kg, were 
operated. 
An anesthetic pentho barbital was used to anesthetize 
the animals. 
• • I 
Antibiotic prophylaxis consisting of cephalexin 20 
mg/kg BW was given as a single dose before surgery. 
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* For cortical bone. 
In each tibia a 2 cm longitudinal skin incision was 
made on the medial surface of the distal portion of the 
tibia tuberosity. The periosteum was reflected and the 
diaphysis was exposed. A 10 x 5 mm^ ( � hole was bored 
through the near cortex into the medullary canal. Bone 
debris was carefully removed by irrigation. The implants 
were inserted tightly into the hole in press fit manner to 
fill whole the way down to the medullaty cavity. According 
to D. Scott Metsger et al, no bone growth was noted when the 
substitutes were placed outside or held loosely. Twenty 
rabbits were separated into four groups. Group I, li, 
III, and IV. Each group has five rabbits, and sacrificed 
after 3, 6, 12, and 24 weeks. 
Every group has : 
3 rabbits right tibiae filled with TCP. 
left tibiae filled with HA. 
1 rabbit right tibia filled with TCP. 
left tibia left empty as a control. 
1 rabbit right tibia left empty as a control, 
left tibia filled with HA. 
The periosteum was not replaced. Closure of muscle and skin. 
* For cancellous bone. 
In each tibia a 1 cm longitudinal skin incision was 
made on the medial surface of the upper portion of the tibia 
tuberosity. The periosteum was reflected and the metaphysis 
was exposed. A hole was bored through the near cortex into 
the medullary canal. Through the hole we curettage 




carefully removed by irrigation. The implants were inserted 
tightly into the hole in press fit manner. Twenty rabbits 
.were separated into four groups. Group V, VI, VII, and VIII. 
Each group, has five rabbits,and sacrificed after 3, 6, 12, 
and 24 weeks. 
Every group has : 
3 rabbits right metaphysis of tibiae filled with TCP. 
left metaphysis of tibiae filled with HA. 
1 rabbit right metaphysis of tibia filled with TCP. 
left metaphysis of tibia left empty as a control. 
1 rabbit right metaphysis of tibia left empty as a control, 
left metaphysis of tibia filled with HA. 
The periosteum was not replaced, closure of muscle and skin. 
By this, we can see how periosteum affect the bone heal. 
I 
Tricalcium phosphate we used is in powder form and 
Hydroxyapatite is in suspension form. Powder form of 
Hydroxyapatite has not biodegradable, so we try the other 
form. By filling the powder form of TCP in press fit manner 
(fill all the way down to medullary canal, till full) there 
should have pore between the powder, but might not created 
homogenize in pore size, we did not care about the pore size 
because till nowadays there is not conclusive optimal pore 
size. 
In this study, I want to know how much these two bone 




After surgery all rabbits were kept in individual 
cages. 
Immediate weight bearing was allowed. 
X ray were taken after surgery arid sacrificed. 
X ray taken after surgery mean to detedt whether there is a 
：丨 
fracture or not and after sacrificed we can see whether 
there is absorbed or not, compare to the x ray taken right 
after operation. 
‘ 
Tetracyclin staining were injected intravenously, 
2 0mg/kg BW. 
For groups I and V, tetracyclin injection were given 
4 day before sacrificed. 
For groups II, iii, vi, and VII, tetracyclin 
injection were given twice, 12, and 4 days before 
sacrificed. 
For groups IV and VIII, tetracyclin injection were 
given thrice, 21, 12 and 4 days before sacrificed. 
Tetracycline labeling technique 
“injection oxytetracycline, dose 20 itig/kg body 
weight 
intravenously 
一 Sample collection; surgical removal 
一 Specimen treatment; dehydration. Methyl-
methacrylate embedding 
一 Undecalcified section, diamond saw >300 um 
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一 Observation, Fluorescence microscope 
一 Tracer for osteoblastic activities 
一 Result: 
New—forming mineiralizing bone 一 一 > yellowish green 
Mature bone --> faint blue 
background --> faint magenta 
一 Applications 
a. Viability checking 
b. Growth rate determination 
3.2.2. Histology. 
Rabbits were sacrificed 3, 6, 12, and 24 weeks, 
following surgery by means of a barbitiirate bverdose. Two 
centimeters lengths of tibiae were remove and placed in 70 % • 丨丨 
alcohol for 3 days. The specimen were then dehydrated and 
embedded in methyl methacrylate in standard manner. 
Embedding medium (Methylmethacrylate) 
Product : RDH 62753 
(A) Removal of methacrylate inhibitor (hydroquinone) 
Preparation of wash solution (1000 ml) 
1. weight 2 00gin of sodium chloride (NaCl) powder 
2. weight 50gm of sodium hydroxide (NaOH) pellet 
3. mix with lOOOml of distilled water. 
Removal of inhibitor 
I 
1. weight 500ml of methacrylate (MMA) 
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2- pour MMA into a lOOOml separating funnel 
3. add in 150ml of wash solution 
4. shake a couple of times and let it settle for 10 
minutes 
5. drain off the bottom part and keep the upper portion 
6. repeat step 3 to 5 for six times 
7. add in 250ml of distilled water 
I 
8. repeat step 4 to 5 
9. repeat step 7 to 8 
10. weight 50gm of anhydrous calcium chloride 
11. pour washed MMA into calcium chloride and shake for 
5 minutes 
12. use double filter paper 
13. store in a bottle, label as Waterfree MMA 
14. keep in refrigerator 
* the removal of inhibitor is recommended to do in a hood 
(B) Preparation of MMA ‘ 
Preparation of unpolymerized MMA (UMMA) 
1. take waterfree MMA out from the refrigerator and let 
it warm up to room temperature before open the cap 
* dehydrated with calcium chloride if required 
. ] ‘ 
2. mix 1.5% of benzoyl peroxide with waterfree MMA ； 
；丨 ‘ 
3. benzoyl peroxide must be dried before use, weight 
out a certain amount and put it in desiccator 
overnight 
4. shake well until dissolve 
5. as soon as the catalyst is dissolved, label it as 
unpolymerized MMA (UMMA) 
6. store in the freezer 
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Preparation of partially polymerized MMA (PMMA) 
1. take waterfree MMA out from the refrigerator and let 
it warm up to room temperature before open the cap 
* dehydrated with calcium chloride if required 
2. mix 3.0% of benzoyl peroxide with waterfree MMA 
3. benzoyl peroxide must be dried before use, weight 
out a certain amount and put it in desiccator 
overnight 
4. shake well until dissolve 
5. allow it to sit at room temperature until the 
monomer is the consistency of honey or thick syrup 
(1-2 weeks) 
6. label this as partially polymerized MMA (PMMA) 
7. store in the freezer. 








Dehydration and embedding 
Reagent Time (2 cm X 2 cm) Condition 
70% alcohol 3 days x 2 changes room temp 
95% alcohol 3 days x 2 changes room temp 
100% alcohol 4 days x 2 changes room temp 
acetone 3 days x 2 changes room temp 
acetone : UMMA 
1 : 1 2 days room temp 
UMMA 3 day^ x 2 changes room temp 




The duration in each solution may change, depend on the size 
and shape of the specimen. 
I - ‘ 
I 
Gelatin coating of glass slides , 
I -
1• Soak glass slides in 2% sodium hydroxide for several 
hours 
2• Rinse in tap water 
3. Neutralize in 2% hydrochloric acid 
4. Rinse well in tap water 
5. Warm the slide up to 50°C in water ' 
6. Coat the slides in chrome alum gelatin solution at 50°C 
for 2 minutes 
7. dry with a dryer 
( 
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Preparation of solution 
a. 2% sodium hydroxide (400 ml) 
weight 8 gm of sodium hydroxide 
dissolve in 400 ml of distilled water 
b. 2% Hydrochloric acid (400 ml) 
weight 32 ml of 25% hydrochloric acid 
add 368 ml of distilled water 
c. Gelatin solution 
I 
gelatin 2.5 gm 
chrom alum 0.25 gm 
dissolve in 500 ml H^O and boil 
keep at 4°C 
Each specimen was cut into thin sections, approximately 500 
um thick, by a diamond saw blade, than grinding and 
polishing on the sand paper to a thick between 100 to 400 urn 
before stained with superficial staining of toluidine blue. 
For cortical bone, we cut them in transversal axis. 
For cancellous bone, we cut them in longitudinal axis. 
I ‘ .I : 
t 
I 
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Prepare of section with thickness (100-400 um) 
一 get section of thickness 500 um from the diamond saw 
一 hand grinding 
一 grind the section on the imperial sand paper 
- o n e of a sand paper is placed on a flat surface (glass) 
-start with grit 1000, 1200,1500 and then grit 2000 
—grind the specimen in clockwise and anticlockwise motion 
5 times on grit 1000, 10 times on grit 1200, 25 times on 
grit 1500 and 50 times on grit 2000 by hand. 
“stick section to gelatinized glass slide by epoxy, which 
smooth surface, face to the glass 
- wrap them with paper and than keep them on compressor, 
till the glue dry usually 2 days 
- then use double side tape to sticJc the slide on a holding 
block 
一 grind the section with sand paper, start with grit 1000, 
1200, and then 1500 and finally end up with grit 2000 
- figure of clockwise and anticlockwise motion are applied 
during grinding 
- 10 times on grit 1000, 25 times on grit 1200, 100 times on 
grit 1500 and 150-200 times on grit 2000 by hand, out come 
thickness about 250 um 
一 polish the saction with imperial lapping film grade 3 mic 
and then 1 mic each grind 200 times 
-lubricate with one drop detergent 




Toluidine blue staining 
a. Preparation of sections 
“thickness of section required 200-400 urn 
“ d o not remove the embedding medium (MMA) 
b- Staining procedure , 
0.1% formic acid 2 min 
tap water i rinse 
20% methanol 120 min 
distilled water rinse 
50°C tolluidine blue 3 ^in 
tap water rinse 
Distilled water rinse well 
c. Mounting 
let air dry or cover by filter paper 
When dry, cover with mounting medium and coverslip 
d. Results 
Cement line - blue 
calcified bone - slightly blue 
osteoid 推 more intensely blue 
Nuclei and cell - weakly stained 
I 
e. Preparation of solution 
Toluidine blue solution 
- 1 gm toluidine blue 
- 1 gm sodium tetraborate 
- 1 0 0 ml distilled water 





3-2.3. Quantitative analysis method. 
The quantity of regenerated bone was measured for 
histomorphometry. The edge of window created was easily 
define by helping of tetracycline and toluidine blue 
staining. 
The microscope was set for x 2.5 magnification. The 
photograph was taken corresponded to whole the window we 
created, for cortical bone and photograph of posterior 
methaphysis was taken, coresponded to an area of 4 x 4 cm^ 
for cancellous bone. ( 4 x 4 cm^ measure from the photo of 
posterior metaphysis in which cancellous bone located) In 
this field regenerated bone was measured, by weighting. 
Interpretation the growth of new bone by using a/a+b as 
a measurement, for cortical bone, (fig. i) a is area of new 
bone growth, a+b is wide of the window created And c/c+d for 
cancellous bone. (fig. 2) c is area of new bone formation, 
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Transverse section a is new bone growth 
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CHAPTER 4 RESULTS. 
Animal study. 
4.1 Cortical bone. 
20 rabbits were utilized. Age between 26 - 31 weeks. 
We separated them into four groups, each group has five 
rabbits, and will be sacrificed 3, 6, 12, and 24 weeks after 
surgery. 
The window created at the shaft of tibiae were 1 X 
O.Scm^. ‘ 
After sacrificed, 2 cm long of tibiae bone were 
embedded in methyl methacrylate with undecalcified manner. 
Then the specimen were cut in transversal axis by diamond 
saw blade, into thin sections, approximately 500 urn thick. 
We grinding and polishing the specimen to about 250 urn thick 
and then stained with toluidine blue in superficial staining 
method. From quantitative analysis we got the result like 
these : I 
Table 2 
Percentage of 丨 TCP | HA 丨 empty 
new bone growth j j 
3 weeks | 0 | 0 I 0 
6 weeks j 10.67 士 15.10 | 17.97 ^ 13.23 j 62.84 ± 18.21 
12 weeks | 36.58 士 10.02 j 39.08 士 30.40 | 65.93 士 3.58 
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Figure 4. Histological appearance of transverse section 
of rabbit‘s tibia, 3 weeks postoperatively, with 
tricalcium phosphate as a bone substitute (x 2.5). 
(1) new bone formation under periosteum 
. I 
(2) margin of window created ov6r the bone, 
looks clean, no new bone growth. 





Figure 5. Histological appearance of transverse section 
of rabbit's tibia, 3 weeks postoperatively, with 
hydroxyapatite as a bone substitute (x 2.5). 
(1) new bone formation under periosteum 
(2) margin of window created over the bone, 
looks clean, no new bone growth 
(3) hydroxyapatite 
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Figure 6. Histological appearance of transverse section 
I 
of rabbit * s tibia, 6 weeks postoperatively, with 
tricalcium phosphate as a bone substitute (x 2.5) 
(1) new bone formation under periosteum, and 
periosteum is not protruding 
(2) margin of window created over the bone, 
looks clean, no new bone|growth 
• _ I 
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Figure 7. Histological appearance of transverse section 
of rabbit's tibia, 6 weeks postoperatively, with 
tricalcium phosphate as a bone substitute (x 2.5) 
(1) new bone formation under periosteum and 
periosteum is protruding 
(2) margin of window created over the bone, 
looks clean, no new bone growth 
‘ 64 
I a： 
. “-U - ： 
. 'I . I 
I . Figure 8. Histological appaerance of transverse section , ji of rabbit's tibi , 6 w eks postop atively, with tric c um phos hate as a bone ubstitute (x 2.5) (1) new bone form ion, under perio um andP r ost um s protr ding2 ma n of w ndow t d over th bone is v d nt
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Figure 9. Histological appearance of transverse section 
of rabbit's tibia, 6 weeks postoperatively, 
without bone substitute (x 2.5) 
(1) new bone formation undeif periosteum, 
|i 
periosteum protrudes over edge. 
(2) margin of window created over the bone, 
new bone growth is evident. 
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Figure 10. Histological appearance of transverse section 
of rabbit‘s tibia, 12 weeks postoperatively, with 
tricalcium phosphate as a bone substitute (x 2.5) 
% 
(1) new bone formation under periosteum, 
periosteum protrudes over edge. 
(2) margin of window created over the bone, 
- I : 
no new bone growth 
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Figure 11. Histological appearance of transverse section 
of rabbit's tibia. 12 weeks postoperatively, with 
• i 
Hydroxyapatite as a bone substitute (x 2.5). 
(1) new bone formation under periosteum 
(2) edge of the window we created, new bone 
is evident as an affect of periosteum. 








‘ ‘ , I 
‘！ 
！ 




Figure 12. Histological appearance of transverse section 
of rabbit‘s tibia. 12 weeks postoperatively, 
the control one (x 2.5) 
(1) new bone growth, periosteum protrudes 
over edge 
(2) edge of window created over the bone, 
new bone is evident. 
� _ 
丨 6 9 
i B p r l 
！ i ‘ 
Figure 13. Histological appearance of transverse section 
of rabbit*s tibia. 12 weeks postoperatively, 
. the control one (x 2.5). 
(1) new bone growth so much, because periosteum 
protrudes longer. 
(2) Edge of the window we created, new bone 
growth was there. 
70 
• I 
_ ‘ ........, 
••“ �：••：；... 
—::】:、.;.,I, 
Figure 14. Histological appearance of transverse section 
of rabbit's tibia. 24 weeks postoperatively, with 
tricalcium phosphate as a bone substitute (x 2.5) 
(1) new bone growth under periosteum 
(2) edge of the window we created, new bone 
is evident 
(3) tricalcium phosphate shown it ability as 
‘ - . . . ！ 
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Figure 15. Histological appearance of transverse section 
of rabbit's tibia. 24 weeks postoperatively, with 
. I 
hydroxyapatite as a bone substitute (x 2.5). 
(1) new bone growth under periosteum 
(2) edge of the window created over the bone, 
new bone is evident over window created 
with similar healing of the window. This 
is an incidental finding in an area where 
the periosteum had good apposition. 
. 1 ： • 






Figure 16 X ray picture of shaft of the rabbit•s tibia 
(1) immediate post operatively. Left tibia filled 
with TCP, and right tibia filled with HA. 
we can not see the HA (granulated suspension 
form)• 
(2) X ray of 3 weeks post operatively, callus were 
shown in both tibia. TCP still there. 
(3) X ray of 24 weeks post operatively, TCP was 
absorbed about 50%. 
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We actually see new bone growth in 3 weeks time post 
operatively, but the new bone growth which we can see only 
located under periosteum, that means not at the edge of the 
window created.(fig.4,5) At 6 and 12 weeks post operative 
groups, we can see new bone growth at the edge of the 
window, but the growth of the new bone are not equal from 
each edge, and we still find part of the edges are clean of 
new bone, so for me these growth is mainly affected by 
periosteum.(fig.8,11) 
‘ A t 24 weeks group, we can say that effect of TCP as an 
osteoconductor was there, because TCP was bonding by new 
bone formation.(fig.14) For HA we can not see its effect 
because the suspension form of HA had already been absorbed 
or diluted by embedding media.(fig.11) 
4-1.1. Role of periosteum in bone healing 
Because the periosteum was not sutured back, some of 
the specimens showed a shrunken periosteum and in some 
the edges of the periosteum were nearly in apposition. In 
the latter case, we found that the healing of the bone was 
» 
faster than in the c^se of the foirmeir, (fig. 15) 
I ‘ 
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Table 3 
！ periosteum protruding 
I TCP 丨 HA I control 
I yes I no I yes | no | yes | no 
new bone | 丨 yes — — — 一 一 — 
formation j 3 wks 
丨 丨no 丨 1 | 7 丨 - 丨 8 | - | 4 
I 丨 y e s 丨 3 丨 - 丨 4 丨 一 丨 4 丨 -
I 6 wks 
I | n o | i | 4 | - | 4 | - -
丨 丨 y 郎 | 7 丨 一 丨 5 丨 一 丨 4 丨 — 
I 12 wks 
I 丨 0 0 丨 1 | 一 丨 1 丨 2 丨 - 丨 一 
I I y e s I 8 丨 一 I 8 1 - 丨 3 -
I 2 4 wks 
no — — 一 _ — 1 
^ I 
From the table above, none of the new bone formation was 
.found at the edge of the window created, in which periosteum 
was not protruding from the edge. 
4.2. Cancellous bone. 
20 rabbits were utilized. Age between 26 一 31 weeks. 
The rabbits were separated int,o four groups, each group has 
five rabbits, and will be sacrificed 3, 6,, 12, and 24 weeks 
post operatively. 
A hole was made by burr at the upper portion of tibia 
tuberositas,and medial surface of the tibia, then through 
the hole we curretaged the cancellous bone. Bone debris was 
carefully removed by irrigation. The implant were inserted 
‘ I I 
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tightly into the medullary canal. The periosteum was not 
replaced. Closure of muscle and skin. After sacrificed, 2 cm 
long of upper portion of tibia were embedded in methyl 
methacrylate .with undecalcified manner, then the specimen 
were cut in longitudinal axis by diamond saw blade, into 
thin sections, approximately 600 urn thick. We grinding and 
polishing the specimen to 100 to 400 um thick and then 
stained with toluidine blue in superficial staining method. 
From quantitative analysis method we got the result like 
these : 
Table 4 
Percentage of 丨 TCP | ha control 
new bone growth | 
3 weeks I 1.15 ± 0.41 | 5.55 士 1.45 | 13.64 ^ 2.96 I 
6 weeks I 27.11 士 12.64 j 15.06 =t 9.81 | 15.00 4.34 
12 weeks | 17.04 士 8.74 j. 39.53 =t 19.30 j 51.71 土 1.53 
24 weeks | 25.68 土 5.48 j 16.76 4.09 | 16.58 0.91 
According to this data, there does not seem to be a 
significant difference between the HA and TCP specimens, as 
regards new bone growth, compared to the control. This may 
be explained by the fact that the tibia plateau of the 
rabbit bone, does not seem to have an adequate amount of 
cancellous bone for the new bone formation. Therefore we may 
conclude that the tibia plateau of the rabbit is not the 
most suitable site for conducting a study on the 
osteoconcJuctive effect of these two bone substitutes. 
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* is TCP, • is H A , ° is control. 
TCP, H A , and control all in, ane line 
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CHAPTER 5 - DISCUSSION 
In the present study calcium phosphate ceramics were 
primarily evaluated as possible substitutes for cancellous 
bone grafts. In view of this application they should be 
bioinert, biodegradable and/or resorbable, and favor bony 
ingrowth at least by conduction and if possible by 
induction. These properties greatly depend on the physical 
and chemical properties of the material, but also on 
structural parameters such as pore size and the width and 
integrity of the partition walls. 
« 
All calcium phosphate ceramics tested were bioinert or 
even bioactive: bone tissue was directly deposited upon the 
inorganic surface. This simply confirms observations made in 
the very first experiments with such compounds. 
Whether hydroxyapatite and tricalcium phosphate are 
resorbable, and to what extent, is still in dispute. 
Resorption rates reported after a period of approximately 
six months vary from 25%-30%, 46%, 30% and 60%, and up to 
100考(7). They depend on manufacturing conditions, porosity, 
implantation site, and animal species. For hydroxyapatite, 
the situations much more controversial. Some authors could 
not detect any resorption. Others observed some degree of 
degradation of the implanted material. Differences in 
preparation conditions and impurities may have been 
partially responsible for this discrepancy. De Groot(1982) 
postulated that these micropores determine the rate of 
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degradation independent of the chemical composition of the 
ceramic and thus are ultimately responsible for 
biodegradability. Macropores, on the other hand, would just 
influence bony ingrowth. Eggli et al.(1988) reported that 
this may be true for tricalcium phosphate. 
One of the study have done by Metsger D. Scott, et.al. 
(1982), the result they got as follow: Fourteen animal 
studies involving the implantation of beta-tricalcium 
phosphate ceramic (TCP) in rats, dogs, and primates have 
shown the material to be effective in repairing many types 
of bony defects. Histological examinations confirm that the 
implant is resorbed and concomitantly replaced by normal 
bone when firmly fixed to freshly cut and bleeding bone. No 
bone growth was noted when the substitutes were placed 
outside, or loosely under the periosteum. Tissue 
compatibility has been shown to be superior to other 
synthetic materials. No adverse reactions attributable to 
TCP have been reported. 
Shimazaki K. and Mooney V.(1985) have done a 
comparative study of Porous Hydroxyapatite and Tricalcium 
Phosphate as Bone Substitute. Three test materials were used 
: H A in large pore form, HA in small pore form, and porous 
TCP. Hydroxyapatite was supplied as a form of a coralline 
hydroxyapatite (CHA), which is made by the conversion of the 
calcium carbonate structure of sea coral into pure HA. 
Coralline Hydroxyapatite-Goniopora (CHAG) hasi the larger 
pores, measuring 600 um in diameter and 260 um in 
intercommunications. Coralline Hydroxyapatite—Porites (CHAP) 
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has a smaller" pore diameter of 230 urn and 190 um 
intercoimnunications. Tricalcium phosphate was prepared from 
Orthograft (Depuy), which was produced from calcium 
phosphate powder by isostatic pressing and then sintered to 
produce a single phase tricalcium block. These block 
therefore have significant variation in pore size and 
interconnection. The pores measure 100 to 3 00 um in 
diameter. All implants for their study were trimmed to a 
cylindrical shape (3 mm in diameter x 8 mm in length). 
Sterilization with ethylene dioxide gas was carried out 
prior to implantation. 
�T h e y utilize eighteen mature female New Zealand 
rabbits. In each tibia a 2 cm longitudinal skin incision was 
made on the medial surface of the distal portion of the 
tibia tuberosity. The periosteum was reflected and the 
diaphysis was exposed. A 3 mm hole was drilled through the 
near cortex into the medullary canal. The implant were 
inserted tightly into the hole in press fit manner. The 
periosteum was replaced followed by layered closure of 
• i 
subcutaneous tissue and skin. 
Table 5. 
Materials implanted in 18 rabbits 
Rabbits 
Material 
3 weeks 12 weeks 24 weeks 
CHAG 4 3 3 
CHAP 5 4 3 
TCP 4 3 4 
Control 3 0 0 
8 0 , 
Table 6 
Histomorphometric results 
Regenerated bone (%) 
Material 3 weeks 12 weeks" 2 4 weeks 
1 7 . 3 去 2 . 5 4 8 . 2 士 4 . 4 5 6 . 1 1 . 6 
CHAP 11 .3 士 1 .9 37 . 7 ± 3 . 6 5 2 . 7 d： i 9 
7 . 0 士 2 . 0 2 9 . 7 士 2 . 0 4 4 . 7 士 5：7 
Control 7.5 土 1.5 
• i 
The conclusions of them : (a) CHAG, CHAP, and TCP can serve 
as bone substitutes that work by providing a scaffold for 
vascular ingrowth, which then leads to bone apposition; (b) 
CHAG was superior in promotion of early bone regeneration 
when compared with other implant materials, (c) TCP was more 
biodegradable than either CHAG or CHAP. 
They only have control for 3 weeks；group and no control 
for 12 and 24 groups, and the result coirie out was not 
different than 3 weeks group of TCP. 
For our study 
Tricalcium phosphate to be used was in powder form, because 
we are not going to search about the pore size. We know, 
while put the Tricalcium phosphate into the window created 
in press fit manner (press the TCP all the way down to 
medullary canal) there should have pore in between the 
powder but might not homogenous. Only by press fit manner we 
can achieve well contact between TCP powder form to the edge 
of window created, and new bone can growth into bone 
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substitute to show osteoconductive effect. Hydroxyapatite ， 
was in granulated suspension, this we choose because the 
powder form of HA have been reported not degradation even 
after prolonged (longer than one year) periods of 
implantation. So we expect to see whether this form of HA 
can be absorb or not. Actually we forgot that if bone 
substitute applied, not in press fit manner or loosely to 
• I 
the edge of the window created, new bone will not growth in 
or osteoconductive effect of bone substitute will not work. 
There is way HA did not show has osteoconductive effect in 
this study. 
For cortical bone. 
Size of the window created was 10 x 5 mm^ ( � ， because 
this is the biggest window can be created, and we want to 
know such wide hole will affect the effect of TCP and HA as 
osteoconductive. 
According to the data we got from our- research and 
statistical finding,(fig.3) shown that there is different 
between using TCP and HA as a bone substitute than the 
control. This does not mean that TCP and HA are good bone 
substitute. However, we still can find edge of the window 
which is clean of new bone growth at 12 weeks group.(fig.ii) 
These may be affected by the gap/window we. created were too 
big for TCP and HA worked as an osteoconductor. 
Osteocunductive effect of TCP can be seen in 24 weeks 
groups.(fig.14) Growth of new bone was not equal from the 
edge of the window, this may be affected by the periosteum 
which was not equally protruding from the edge of the window 
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created.(fig,l2,13) We can say that, because according to 
this study in every edge of the window in which new bone 
formation was evident, the periosteum should be protruding 
from the edge of the window created. None of them in which 
periosteum was not protruding from the edge of the window 
created,and new bone formation was there.(table 3) 
Histological finding was that new bone formation growth in 
proportion to the periosteum.(fig.12,13) 
‘ . . . 
Many animal study have been done on these bone 
substitute and give reasonable good result, but one thing we 
have to pay attention is that all of them suture the 
periosteum back. So for me, periosteum maybe the main key 
for bone to heal. AS we known periosteum has osteoinduct 
effect (18).This can be prove by our 3 weeks specimen, in 
which new bone formation is already there, (fig.4,5) Powder 
form of TCP has osteoconductive effect which can be prove by 
the result of our 24 weeks specimen,(fig.14) TCP was bonded 
by new bone formation. At this times new bone growth as an 
affect of periosteum has make the distance between the edge 
of the gap, was not as wide as created. So can be said that 
osteoconductive effect of TCP is not able to work in such 
wide of the window we created. 
X ray were taken after surgery and sacrificed. 
From the x ray we can definitely see that about 50% of TCP 
had been absorbed at groups 24 weeks, but HA was not easily 
detect.(fig.16) 
• • i 
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Tetracycline staining 
Multiple staining were applied, the aim is want to have 
different sharp of fluorescences so can also known how much 
new bone growth was found in between the period of staining. 
For groups 24 weeks, Tetracycline injection were given 
thrice, 21, 12, and 4 days before sacrificed, but can not 
find what actually want to gain. This may be the dose was 
not adequate 
For cancellous bone. 
According to statistic finding there was not 
significantly different between TCP and HA to the control. 
One of the reason may be cortical bone of tibia plateau is 
too little, so I do not think that the tibia plateau of 
rabbit is the right choice for tested.(fig.17) 
. 丨 \ 
CONCLUSION 
1. By not suture back the periosteum we can not count how 
much the percentage of bone substitute had been absorbed. 
2• New bone formation is shown in 3 weeks postoperative 
specimen, which is located under periosteum. Inner surface 
of periosteum has osteoinductive effect, so while treat a 
fracture, we also need to pay attention to periosteum, if 
the inner surface facing out this may be one of the source 
of spur formation occur. 
8 4 、 
3. New bone growth in to the bone substitute only found in 
the tricalcium phosphate group, this because the TCP group 
can be fit in press fit manner, so TCP can firmly contact to 
freshly cut and bleeding bone. HA can not shown its 
osteoconductive effect because the form of HA we used could 
« 
not apply in press fit manner. 
4. Periosteum affect the bone healing, as we can see 
majority new bone growth in the site where periosteum is 
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APPENDIX 
Data of cortical bone 
Percentage of new bone growth | TCP | HA I control 
I 0 I 0 I 0 
3 weeks postoperation I o 0 0 
I 0 丨 0 丨 0 
丨 0 丨 0 I 0 
I 0 I 0 I 
> 
6 weeks postoperation | o | 1 6 . 2 8 7 5 . 7 1 
I 10.65 I 26.0 I 49.96 
I 32.03 I 29.58 | 
i 45.0 I 35.49 I 
12 weeks postoperation | 4 4 . 4 7 I 47.72 6 3 . 4 0 
I 24.23 I 73.10 I 68.46 
i I 32•62 I 0.00 I 
I 30.08 I 48.51 I 
24 weeks postoperation | 35.33 | 26.49 | 14.40 
I 54.59 I 41.81 I 16.37 
I 58.91 I 29.36 | 
. ‘ • . 1 
1 
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Data of cancellous bone 
Percentage of new bone growth | TCP | HA I control 
I 1.70 I 6.17 I 
3 weeks postoperation | 1.23 | 7.23 | 15.73 
I 0.86 I 4.87 11.55 
• i -
t 
I 0.81 I 3.92 I 
I 44.75 I 11.65 I 
6 weeks postoperation | 16.48 | 8.42 | 18.42 
I 27.51 I 29.64 | 11.57 
I 19.70 I 10.52 I 
I 20.37 I 44.58 | 
12 weeks postoperation | 13.77 | 64.53 | 52.79 
I 27,19 I 27.21 I 50.62 
I 6.82 I 21.78 I 
• " ‘ " ' ‘ “ ‘ ‘ “ “ ‘ •"'•" • • 
I 27.12 I 22.85 | 
24 weeks postoperation | 21.26 | 14.74 | 16.45 
丨 33.56 I 13.71 丨 17.73 
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